Technology area: Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Celltrion Inc. maintains a patent portfolio with 2 pending office actions focused within the Transportation, E-Commerce & Mechanical Systems technology area. These active matters are distributed across 2 distinct examiners, showing that the workload is divided among the 2 distinct examiners at the patent office. Despite the involvement of multiple examiners, the prosecution is centralized within 1 distinct art unit, suggesting a specific technical focus for the current filings.
The busiest examiner for the portfolio is TIWARI, VYOMA SHUBHAM, who is responsible for 1 busiest examiner pending action. This figure represents a portion of the total 2 pending office actions currently active for the company. Practitioners can expect a concentrated level of examiner engagement within this 1 distinct art unit, as the company navigates its current filings within its designated Transportation, E-Commerce & Mechanical Systems technology area at the USPTO office to secure its intellectual property rights. Success depends on the engagement with TIWARI, VYOMA SHUBHAM to resolve the 1 busiest examiner pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TIWARI, VYOMA SHUBHAM | 1 | 31.5% | +48.1% |
| KOLOSOWSKI-GAGER, KATHERINE | 1 | 26.6% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269549 | Clinical Supplies Management Method And Device Using Same | KOLOSOWSKI-GAGER, KATHERINE | 20d |
| 18959294 | Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use Thereof | TIWARI, VYOMA SHUBHAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269549 | Clinical Supplies Management Method And Device Using Same | KOLOSOWSKI-GAGER, KATHERINE | 20d |
| 18959294 | Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use Thereof | TIWARI, VYOMA SHUBHAM | — |
| Art Unit | Apps |
|---|---|
| 3687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959294 | Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use Thereof | TIWARI, VYOMA SHUBHAM | — | §102§103§112Other | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18269549 | Clinical Supplies Management Method And Device Using Same | KOLOSOWSKI-GAGER, KATHERINE | 3687 | §101 | Non-Final OA | 20d | Pending | Jul 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial